FDA Guidance for Industry: Child-Resistant Packaging Statements in Drug Product Labeling

Title:
FDA Guidance for Industry: Child-Resistant Packaging Statements in Drug Product Labeling
Origin/Publisher:

FDA, https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM569607.pdf

Content:
This guidance is intended to assist applicants, manufacturers, packagers, and distributors (collectively referred to as firms) who choose to include child-resistant packaging (CRP) statements in their drug product labeling.

Go back